Avai Bio (AVAI) Other Accumulated Expenses (2018 - 2025)

Avai Bio has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $698034.0 for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $698034.0, up 29.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $698034.0 (up 29.0% YoY), and the FY2025 annual result was $512075.0, up 25.89% from the prior year.
• Other Accumulated Expenses came in at $698034.0 for Q4 2025 at Avai Bio, roughly flat from $700383.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $700383.0 in Q3 2025 to a low of $2816.0 in Q1 2022.
• The 4-year median for Other Accumulated Expenses is $586507.0 (2024), against an average of $503924.5.
• Across the five-year window, Other Accumulated Expenses jumped 8572.51% in 2023 and dropped 0.47% in 2025, its largest moves.
• Avai Bio's Other Accumulated Expenses stood at $2816.0 in 2022, then surged by 8572.51% to $244218.0 in 2023, then surged by 121.57% to $541123.0 in 2024, then increased by 29.0% to $698034.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $698034.0 (Q4 2025), $700383.0 (Q3 2025), and $631891.0 (Q2 2025), per Business Quant data.